Description
Nitrofurantoin 100mg Tablets
Nitrofurantoin is an antibiotic medication commonly used to treat urinary tract infections (UTIs). It belongs to a class of drugs known as fluoroquinolones and is primarily used to prevent the growth of bacteria in the urinary tract. Nitrofurantoin is available in oral tablet form under the brand name Nitrofurantoin 100mg Tablets.
Dosage and Administration
Nitrofurantoin 100mg Tablets are prescribes for the treatment of uncomplicated UTIs in adults. The recommends dosage is 100 mg taken orally twice a day for 5-7 days. It is important to follow the instructions provided by your healthcare provider to ensure the correct dosage and duration of treatment.
Mechanism of Action
Nitrofurantoin works by inhibiting the bacterial enzyme responsible for making tetrahydrofolic acid, an essential component of DNA synthesis. By inhibiting this process, Nitrofurantoin disrupts the bacterial growth and reproduction, leading to its therapeutic action against UTIs.
Side Effects
While Nitrofurantoin is generally acceptable, some common side effects that have been reporting includes:
1. Nausea and vomiting
2. Abdominal pain
3. Diarrhea
4. Headache
5. Skin rash
6. Itching
If you experience any severe or persistent side effects, it is important to consult with your healthcare provider.
Precautions
Before taking Nitrofurantoin 100mg Tablets, it is important to tell your healthcare provider about any other medications you are taking, as well as any allergies or medical conditions you may have. This medication should be use with caution in individuals with kidney problems, liver disease, or a history of allergic reactions to sulfonamide antibiotics.
Conclusion
Nitrofurantoin 100mg Tablets are a convenient and effective treatment option for uncomplicated UTIs in adults. However, it is important to follow your healthcare provider’s instructions and take this medication as directed. If you are experiencing any severe or persistent side effects, seek medical attention promptly.
Reviews
There are no reviews yet.